Patents Assigned to Immunom Technologies, Inc.
  • Patent number: 8759309
    Abstract: The polynucleotides of the present invention are complementary to the Initiation Sites of microbes. Invading organisms, sensing the pH and nutrient deprivation of a physiologic environment quickly release these nucleotides triggering rapid growth and mutation—attributes to successfully establishing a nidus of infection. They also stimulate neutrophil functions. Accordingly, the nucleotides, compositions and methods of the present invention may be used to enhance, restore or stimulate an immune response or system of an animal, e.g. to prevent an infection caused by a microorganism, ameliorate an infection caused by a microorganism, or kill an invading microorganism that causes infection or re-establish balance to an immune system. In particular, the polynucleotides, compositions and methods of the present invention may be used to treat or prevent bacterial infections and auto-immune diseases in a mammal in need thereof.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: June 24, 2014
    Assignee: Immunom Technologies, Inc.
    Inventor: William E. Marshall
  • Publication number: 20110268763
    Abstract: The polynucleotides of the present invention are complementary to the Initiation Sites of microbes. Invading organisms, sensing the pH and nutrient deprivation of a physiologic environment quickly release these nucleotides triggering rapid growth and mutation—attributes to successfully establishing a nidus of infection. They also stimulate neutrophil functions. Accordingly, the nucleotides, compositions and methods of the present invention may be used to enhance, restore or stimulate an immune response or system of an animal, e.g. to prevent an infection caused by a microorganism, ameliorate an infection caused by a microorganism, or kill an invading microorganism that causes infection or re-establish balance to an immune system. In particular, the polynucleotides, compositions and methods of the present invention may be used to treat or prevent bacterial infections and auto-immune diseases in a mammal in need thereof.
    Type: Application
    Filed: February 22, 2011
    Publication date: November 3, 2011
    Applicant: IMMUNOM TECHNOLOGIES, INC.
    Inventor: WILLIAM E. MARSHALL
  • Patent number: 6589771
    Abstract: A method for arousing dormant bacteria. The method comprises inducing diffusion of intracellular solutes from dormant bacteria and then allowing an adjustment period for a length of time sufficient to initiate arousal. The decrease in intracellular osmolality or pH can be induced by methods such as extraction, dilution, or dialysis. The method has been standardized using Dulbecco's phosphate buffered saline as the solution. The aroused bacteria can then be selected or recovered by growing them on media for a period of time. If the adjustment period is prolonged, many bacteria can become hypermutative.
    Type: Grant
    Filed: October 28, 1999
    Date of Patent: July 8, 2003
    Assignee: Immunom Technologies, Inc.
    Inventor: William E. Marshall
  • Patent number: 5840318
    Abstract: Methods and compositions for modulating the immune system of animals by activating macrophages to release cytokines and down-regulating their sensitivity to bacterial endotoxin and to conversion to cytotoxic phenotypes by the administration of stress response factors released by stressed bacteria.Methods and compositions for protecting the viability of liquid or dried cultures of bacteria by the administration of stress response factors released by stressed bacteria.
    Type: Grant
    Filed: October 29, 1996
    Date of Patent: November 24, 1998
    Assignee: Immunom Technologies, Inc.
    Inventors: William E. Marshall, Michael K. Hoffmann